First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.
Publication year
2023Author(s)
Source
Journal of the Pediatric Infectious Diseases Society, 12, 11, (2023), pp. 581-585ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Clinical Pharmacy
Journal title
Journal of the Pediatric Infectious Diseases Society
Volume
vol. 12
Issue
iss. 11
Page start
p. 581
Page end
p. 585
Subject
Radboudumc 4: lnfectious Diseases and Global Health Clinical Pharmacy; Radboud University Medical CenterAbstract
Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared with reference values for adults, supporting studies on increased doses of first-line TB drugs in infants.
This item appears in the following Collection(s)
- Academic publications [245263]
- Electronic publications [132514]
- Faculty of Medical Sciences [93208]
- Open Access publications [106120]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.